|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-3-15
|
|
pubmed:abstractText |
To determine the most cost-effective strategy using PET for mediastinal staging of potentially operable non-small-cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0009-9260
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
479-92
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15767106-Aged,
pubmed-meshheading:15767106-Biopsy,
pubmed-meshheading:15767106-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15767106-Cost-Benefit Analysis,
pubmed-meshheading:15767106-Decision Trees,
pubmed-meshheading:15767106-France,
pubmed-meshheading:15767106-Humans,
pubmed-meshheading:15767106-Insurance, Health,
pubmed-meshheading:15767106-Life Expectancy,
pubmed-meshheading:15767106-Lung Neoplasms,
pubmed-meshheading:15767106-Lymphatic Metastasis,
pubmed-meshheading:15767106-Neoplasm Staging,
pubmed-meshheading:15767106-Positron-Emission Tomography,
pubmed-meshheading:15767106-Sensitivity and Specificity,
pubmed-meshheading:15767106-Tomography, X-Ray Computed
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.
|
|
pubmed:affiliation |
CEC-Inserm, Service d'Epidémiologie et Evaluation Cliniques, C.H.U. de Nancy, Nancy, France.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
